Final OK On $1.2B Valeant Deal Earns Robbins Geller $157M
A New Jersey federal judge gave final approval on Monday to a $1.2 billion settlement of an investor action against Valeant Pharmaceuticals, landing lead counsel Robbins Geller Rudman & Dowd LLP...To view the full article, register now.
Already a subscriber? Click here to view full article